NCT05950295View on ClinicalTrials.gov

Intranasal Lavage With Hypochlorous Acid Safely Reduces the Symptoms in the Ambulatory Patient With COVID-19.

CompletedOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

September 24, 2020

Primary Completion Date

March 13, 2021

Study Completion Date

April 13, 2021

Conditions
COVID-19
Interventions
OTHER

Intranasal lavage with hypochlorous acid solution

intranasal lavage for ten days

Trial Locations (1)

19610

Tower Health/Reading Hospital, Reading

All Listed Sponsors
lead

Monique Lisa Abner

OTHER

NCT05950295 - Intranasal Lavage With Hypochlorous Acid Safely Reduces the Symptoms in the Ambulatory Patient With COVID-19. | Biotech Hunter | Biotech Hunter